Baylis Medical Technologies Launches PowerWire? Pro for Commercial Treatment of In-Stent Restenosis

6 June 2024

Baylis Medical Technologies has announced the successful completion of the first clinical use of its PowerWire® Pro Radiofrequency (RF) Guidewire.

The patient suffered from a chronically occluded stent extending from the inferior vena cava (IVC) down to the left common iliac vein. Previous attempts using mechanical tools were unsuccessful due to the dense fibrotic nature of the occlusion.

However, Dr. Iafrati successfully used the PowerWire Pro RF Guidewire, which utilizes RF energy to vaporize a channel through occlusions, enabling the crossing and subsequent revascularization of the iliocaval stent.

The significance of this advancement, particularly in treating in-stent restenosis, stating, "This technology proved pivotal in navigating occluded stents where conventional tools fell short."

The PowerWire Pro RF Guidewire was cleared by the FDA this spring, marking a significant milestone for Baylis Medical Technologies.

Designed to negotiate occluded peripheral vessels, including those with stents, using radiofrequency technology, this device promises to streamline revascularization procedures.

"This innovation aims to simplify the often challenging and time-consuming process of crossing chronic occlusions in revascularization procedures, ensuring uninterrupted patient treatment."

 

 

 

 

 

 

Source: prnewswire.com